PMID: 518286Nov 1, 1979Paper

Effects of testosterone undecanoate on sexual potency and the hypothalamic-pituitary-gonadal axis of impotent males

Archives of Sexual Behavior
O BenkertA Leitz

Abstract

A double-blind comparison was made of the effects of testosterone undecanoate (TU) and placebo on sexual potency of 29 impotent men ages 45--75. The main criteria for inclusion in the study were a reduced or nonexistent capacity to have an erection during intercourse and no clinical signs of endocrinological pathology. All patients received placebo for 2 weeks. Then TU was given at a daily dose of 120 mg to 13 patients selected at random while the other patients continued to receive placebo. After 8 weeks all patients received placebo again for 2 weeks. An improvement in sexual potency was reported by five patients given TU and eight patients given placebo, with no significant differences between the groups. Treatment with TU influenced neither the hypothalamic-pituitary-gonadal axis, as judged by levels of prolactin, LH, FSH, and the LHRH-induced LH/FSH response, nor depression, anxiety, and somatic scores or performance tests. The only specific effect of TU treatment was to decrease the total plasma testosterone level. The present findings show pharmacotherapy with androgens to be no more effective than placebo in restoring sexual potency to sexually impotent men without androgen deficiency. Further studies may be needed to e...Continue Reading

References

Oct 1, 1978·Clinical Endocrinology·P FranchimontR Roulier
Apr 1, 1977·European Journal of Clinical Investigation·E NieschlagE J Wickings
Jan 1, 1975·Neuropsychobiology·O BenkertG Gammel
Sep 1, 1975·Acta Endocrinologica·C HirschhäuserA Coert
Jan 1, 1974·Clinical Endocrinology·D C Anderson
Aug 15, 1974·FEBS Letters·K E Mickelson, P H Petra
Jan 1, 1959·The British Journal of Medical Psychology·M HAMILTON

❮ Previous
Next ❯

Citations

Feb 10, 2009·Advances in Therapy·U Srinivas-Shankar, D Sharma
Nov 20, 1990·The Journal of Steroid Biochemistry and Molecular Biology·G FrajeseD Nerozzi
Jan 31, 2002·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Alvin M Matsumoto
Nov 28, 1997·Postgraduate Medical Journal·N Burns-Cox, C Gingell
Jan 22, 2005·Annual Review of Medicine·Rabih A Hijazi, Glenn R Cunningham
Oct 6, 2005·Annals of General Psychiatry·Wouter De la MarcheRobert F Ferdinand
Jan 1, 1984·Journal of Sex & Marital Therapy·J Bancroft
Apr 5, 2014·The Journal of Sexual Medicine·Giovanni CoronaMario Maggi
Mar 6, 2016·The Journal of Sexual Medicine·Giovanni CoronaMario Maggi
Jan 27, 1999·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·S N Seidman, B T Walsh
Nov 18, 2005·The Urologic Clinics of North America·John L GoreJacob Rajfer
Sep 27, 2005·Clinical Endocrinology·Andrea M IsidoriAndrea Lenzi
Jun 21, 2011·The American Journal of Medicine·Abdulmaged M TraishMichael Zitzmann
Jan 1, 1988·Journal of the American Geriatrics Society·T Mulligan, P G Katz
Nov 1, 1982·Clinics in Endocrinology and Metabolism·K M Pirke, G Kockott
Feb 4, 2003·Expert Opinion on Pharmacotherapy·Laurence M Demers
Sep 23, 2016·PloS One·Samantha HuoAdriane Fugh-Berman
Jul 14, 2000·The Journal of Urology·P JainK T McVary
Feb 20, 2009·International Journal of Impotence Research·M H Emmelot-VonkY T van der Schouw
Jan 6, 2006·International Journal of Impotence Research·S N Seidman
Apr 30, 2002·International Journal of Impotence Research·J CerqueiraS Glina
May 20, 2005·Endocrine Reviews·Jean M Kaufman, Alex Vermeulen
Aug 1, 1984·The British Journal of Psychiatry : the Journal of Mental Science·R O'Carroll, J Bancroft
Jan 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·K Hawton
May 15, 2009·Journal of Clinical Psychopharmacology·Stuart N SeidmanMark Weiser
Jan 22, 2003·Journal of the American Geriatrics Society·David A Gruenewald, Alvin M Matsumoto
Feb 1, 2005·BJU International·Eric J H Meuleman, Jacques J D M van Lankveld

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.